
The aim of this retrospective study is to evaluate the zzso experience using gamma knife zzso in the management of primary zzso zzso 

Fourteen patients, six males and eight zzso with ages ranging from 7 to 56 years of age, were treated with gamma knife zzso from April 2001 to June 2005 for primary zzso zzso The median prescription peripheral dose was 16 zzso ranging from 15 to 20 zzso and the median maximum dose was 32 zzso ranging from 30 to 40 zzso The median volume of the zzso at zzso was zzso zzso zzso zzso zzso to zzso zzso The mean dose to zzso nerve was below 10 zzso A mean of 10 zzso zzso 8 to zzso were used for treating these zzso 

At a median follow-up period of 36 months zzso 18 to 66 zzso zzso zzso and zzso resolved in 10 zzso Two of the remaining four patients showed evidence of decrease in zzso while the other two remain zzso The median time of their presenting symptoms resolving was 7 months zzso 3 to 18 zzso One patient lost her sight 18 months after gamma knife zzso No patient had zzso zzso after zzso 

zzso knife zzso provides effective long-term relief of symptoms in selected patients with primary zzso zzso 

